Bellevue Group AG - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$84,728,000
+74.8%
4,492,466
+9.1%
1.58%
+90.3%
Q2 2019$48,478,000
+176.0%
4,118,806
+220.1%
0.83%
-14.3%
Q1 2019$17,564,000
+52.5%
1,286,748
+14.5%
0.97%
+27.6%
Q4 2018$11,519,000
-23.6%
1,123,813
+24.1%
0.76%
-20.8%
Q3 2018$15,072,000
+25.7%
905,254
+19.3%
0.96%
-6.5%
Q2 2018$11,992,000
+34.8%
758,964
+8.4%
1.02%
+16.0%
Q1 2018$8,896,000
+2441.7%
700,464
+2189.1%
0.88%
+2281.1%
Q4 2017$350,000
-13.4%
30,600
-7.3%
0.04%
-11.9%
Q3 2017$404,000
+6.9%
33,0000.0%0.04%
-6.7%
Q2 2017$378,000
-44.9%
33,0000.0%0.04%
-50.5%
Q1 2017$686,0000.0%33,0000.0%0.09%
-35.0%
Q4 2016$686,000
-36.5%
33,0000.0%0.14%
-28.2%
Q3 2016$1,081,000
+31.2%
33,0000.0%0.20%
+25.8%
Q2 2016$824,000
+2.0%
33,0000.0%0.16%
+5.4%
Q1 2016$808,00033,0000.15%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,628,328$33,869,00014.72%
Foresite Capital Management II, LLC 995,396$20,704,00010.39%
Cormorant Asset Management, LP 1,581,604$32,897,0004.43%
DAFNA Capital Management LLC 221,013$4,597,0004.04%
New Leaf Venture Partners, L.L.C. 228,428$4,751,0003.40%
Partner Investment Management, L.P. 63,571$1,322,0001.75%
Iguana Healthcare Management, LLC 140,000$2,912,0001.74%
PFM Health Sciences, LP 2,913,951$60,610,0001.71%
Redmile Group, LLC 920,550$19,147,0001.65%
SECTORAL ASSET MANAGEMENT INC 669,351$13,923,0001.54%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders